Dr Thomas Bonnard is a research fellow in Dr Christoph Hagemeyer's Nanobiotechnology laboratory of the Australian Centre for Blood Diseases. He is funded by a William Harvey Translational Research Fellowship from the European Union. He was recently profiled by thelimbic.com for his work, in his own words, on "improv[ing]heart disease treatment with nanomedical devices."
See more: Designer molecule offers targeted thrombolysis at the site of blood clots
See more: Designer molecule offers targeted thrombolysis at the site of blood clots
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.